Aclarion (ACONW) Capital Expenditures (2024 - 2025)
Aclarion (ACONW) reported Capital Expenditures of $13726.0 for Q4 2025, up 168.35% on a YoY basis from $5115.0 in Q4 2024, and up 87.49% quarter-over-quarter from $7321.0 in Q3 2025.
Aclarion (ACONW) Capital Expenditures (2024 - 2025) Analysis & Trends
Aclarion has reported Capital Expenditures for 2 years, with the latest figure at $13726.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures rose 168.35% year-over-year to $13726.0; the trailing twelve-month figure through Dec 2025 stood at $26162.0 (changed N/A YoY), and the FY2025 full-year result was $21528.0, up 320.88% from the prior year.
- Capital Expenditures for Q4 2025 stood at $13726.0, up from $7321.0 in the prior quarter.
- The five-year high for Capital Expenditures was $13726.0 in Q4 2025, with the low at $5115.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.75 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.67 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 15.93 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 28,000.00 |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 118,000.00 |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 2.25 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 15.33 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 12.44 Mn |
| 10 | Aclarion | - | - | 3,750.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,726.00 |
| Dec 31, 2025 | 13,726.00 |
| Sep 30, 2025 | 7,321.00 |
| Sep 30, 2025 | 7,321.00 |
| Dec 31, 2024 | 5,115.00 |
| Dec 31, 2024 | 5,115.00 |